Pharmaceuticals · Pharmaceuticals: Major · NSE: APLLTD · data 2026-10-30

Alembic Pharmaceuticals Limited

₹797.85+0.38% on 30 OctHealth: Strong 6.9/10

Feb 2026Low ₹646.55 · High ₹863.75+0.0%

In plain words

Price: 20.1% below its 52-week high of ₹998.

Delivery: 56.8% of traded shares were kept for delivery over the last 10 sessions, against 53.0% over the last 60.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹797.85

Market cap

₹15,630 cr

P/E

22.6

P/B

—

ROE

12.3%

ROCE

11.8%

Debt / equity

0.25

Dividend yield

1.51%

1-year return

-11.4%

52-week high

₹998

52-week low

₹635.8

Operating margin

10.6%

Growth

Revenue (last 12 months)	₹7,784 cr
Net profit (last 12 months)	₹693 cr
Sales growth, 3 years (yearly)	9.0%
Profit growth, 3 years (yearly)	25.4%

Smart-money activity

17/100 · Weak over the last ~60 sessions, data 2026-10-30

Delivery vs usual 4/30: Delivery 57.9% over the last 20 sessions vs 50.5% in the 40 before (1.15x); shares delivered per day 0.86x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
Accumulation evidence 8/15: Verdict "Building", sustained score 48/100.
Promoter pledges 5/5: No promoter pledge filings in 90 days.

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Story so far

● Dividend

29 Jul 26Dividend Dividend ₹12 (ex-date) -2.0% next session
29 Jul 25Dividend Dividend ₹11 (ex-date) +0.7% next session

From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.

Common questions

Is Alembic Pharmaceuticals Limited debt-free?

Its latest reported debt-to-equity ratio is 0.25.

What is Alembic Pharmaceuticals Limited's P/E ratio?

About 22.6, based on the last 12 months' earnings and a price of ₹797.85 (data 2026-10-30).

What is the 52-week high and low of Alembic Pharmaceuticals Limited?

The 52-week high is ₹998 and the 52-week low is ₹635.8.

Similar companies

Eris Lifesciences Ltd (ERIS) · AstraZeneca Pharma India Limited (ASTRAZEN) · NATCO Pharma Limited (NATCOPHARM) · Jubilant Pharmova Limited (JUBLPHARMA) · Indegene Limited (INDGN)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open APLLTD in NSE Scanner →